Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Biomarkers for cholangiocellular carcinoma (CCC)

Biomarkers for cholangiocellular carcinoma (CCC)

US Patent 10429391 · Granted Oct 1, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Targets for use in diagnosis, prognosis and therapy of cancer2014
Biomarkers for inflammation of the liver2013
Biomarkers for inflammation of the liver2013
Targets for use in diagnosis, prognosis and therapy of cancer2012
Methods for predicting the response of multiple sclerosis patients to interferon2011
Use of(R)-(−) -2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and it2011
Use of 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physio2011
Multi-factor authentication2010
Method for differentiating malignant from benign thyroid tissue2010
Use of substituted aminomethyl chromans2009
Processing proteins from gels for analysis using mass spectrometry2003
Enhancer for eukaryotic expression systems2001